Substance / Medication

Metaraminol

Overview

Active Ingredient
metaraminol
RxNorm CUI
6805

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Metaraminol use during spinal anaesthesia for caesarean section: a meta-analysis of randomised controlled trials.
Chao E, Sun H-L, Huang S-W et al. · Int J Obstet Anesth · 2019
PMID: 30772119Meta-Analysis
Comparison of metaraminol versus no metaraminol on time to resolution of shock in critically ill patients.
Abu Sardaneh Arwa, Penm Jonathan, Oliver Matthew et al. · Eur J Hosp Pharm · 2023
PMID: 34620686ObservationalFull text (PMC)
Pharmacoepidemiology of metaraminol in critically ill patients with shock in a tertiary care hospital.
Sardaneh Arwa Abu, Penm Jonathan, Oliver Matthew et al. · Aust Crit Care · 2021
PMID: 33663948Observational
Norepinephrine and metaraminol in septic shock: a comparison of the hemodynamic effects.
Natalini Giuseppe, Schivalocchi Valeria, Rosano Antonio et al. · Intensive Care Med · 2005
PMID: 15803299Observational
Relative uptake, metabolism, and beta-receptor binding of (1R,2S)-4-(18)F-fluorometaraminol and (123)I-MIBG in normotensive and spontaneously hypertensive rats.
Pissarek Margit, Ermert Johannes, Oesterreich Guido et al. · J Nucl Med · 2002
PMID: 11884497Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Metaraminol (substance)
SNOMED CT
372728001
UMLS CUI
C0025575
RxNorm CUI
6805

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.